Therapy-induced tumour secretomes promote resistance and tumour progression (Q35867131)

From Wikidata

Jump to navigation Jump to search

scientific article published on 25 March 2015

edit

Language	Label	Description	Also known as
English	Therapy-induced tumour secretomes promote resistance and tumour progression	scientific article published on 25 March 2015

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PMC publication ID

4507807

retrieved

10 August 2017

title

Therapy-induced tumour secretomes promote resistance and tumour progression (English)

1 reference

stated in

Europe PubMed Central

PMC publication ID

4507807

retrieved

10 August 2017

main subject

secretome

1 reference

based on heuristic

inferred from title

tumor progression

1 reference

based on heuristic

inferred from title

author

Anna C Obenauf

series ordinal

1

1 reference

stated in

Europe PubMed Central

PMC publication ID

4507807

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25807485%20AND%20SRC:MED&resulttype=core&format=json

retrieved

7 June 2020

Yilong Zou

series ordinal

2

1 reference

stated in

Europe PubMed Central

PMC publication ID

4507807

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25807485%20AND%20SRC:MED&resulttype=core&format=json

retrieved

7 June 2020

Hubing Shi

series ordinal

6

1 reference

stated in

Europe PubMed Central

PMC publication ID

4507807

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25807485%20AND%20SRC:MED&resulttype=core&format=json

retrieved

7 June 2020

Thomas Wiesner

series ordinal

9

1 reference

stated in

Europe PubMed Central

PMC publication ID

4507807

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25807485%20AND%20SRC:MED&resulttype=core&format=json

retrieved

7 June 2020

Joan Massagué Solé

series ordinal

12

1 reference

stated in

Europe PubMed Central

PMC publication ID

4507807

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25807485%20AND%20SRC:MED&resulttype=core&format=json

retrieved

7 June 2020

author name string

Andrew L Ji

series ordinal

3

1 reference

stated in

Europe PubMed Central

PMC publication ID

4507807

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25807485%20AND%20SRC:MED&resulttype=core&format=json

retrieved

7 June 2020

Sakari Vanharanta

series ordinal

4

1 reference

stated in

Europe PubMed Central

PMC publication ID

4507807

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25807485%20AND%20SRC:MED&resulttype=core&format=json

retrieved

7 June 2020

Weiping Shu

series ordinal

5

1 reference

stated in

Europe PubMed Central

PMC publication ID

4507807

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25807485%20AND%20SRC:MED&resulttype=core&format=json

retrieved

7 June 2020

Xiangju Kong

series ordinal

7

1 reference

stated in

Europe PubMed Central

PMC publication ID

4507807

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25807485%20AND%20SRC:MED&resulttype=core&format=json

retrieved

7 June 2020

Marcus C Bosenberg

series ordinal

8

1 reference

stated in

Europe PubMed Central

PMC publication ID

4507807

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25807485%20AND%20SRC:MED&resulttype=core&format=json

retrieved

7 June 2020

Neal Rosen

series ordinal

10

1 reference

stated in

Europe PubMed Central

PMC publication ID

4507807

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25807485%20AND%20SRC:MED&resulttype=core&format=json

retrieved

7 June 2020

Roger S Lo

series ordinal

11

1 reference

stated in

Europe PubMed Central

PMC publication ID

4507807

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25807485%20AND%20SRC:MED&resulttype=core&format=json

retrieved

7 June 2020

language of work or name

English

0 references

publication date

25 March 2015

1 reference

stated in

Europe PubMed Central

PMC publication ID

4507807

retrieved

10 August 2017

published in

Nature

1 reference

stated in

Europe PubMed Central

PMC publication ID

4507807

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25807485%20AND%20SRC:MED&resulttype=core&format=json

retrieved

7 June 2020

volume

520

1 reference

stated in

Europe PubMed Central

PMC publication ID

4507807

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25807485%20AND%20SRC:MED&resulttype=core&format=json

retrieved

7 June 2020

issue

7547

1 reference

stated in

Europe PubMed Central

PMC publication ID

4507807

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25807485%20AND%20SRC:MED&resulttype=core&format=json

retrieved

7 June 2020

page(s)

368-372

1 reference

stated in

Europe PubMed Central

PMC publication ID

4507807

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25807485%20AND%20SRC:MED&resulttype=core&format=json

retrieved

7 June 2020

describes a project that uses

ImageJ

1 reference

stated in

Europe PubMed Central

retrieved

11 June 2022

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/PMC4507807/fullTextXML

based on heuristic

inferred from PubMed Central ID database lookup

cites work

Blocking PGE2-induced tumour repopulation abrogates bladder cancer chemoresistance

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4507807

retrieved

27 July 2018

Drug resistance via feedback activation of Stat3 in oncogene-addicted cancer cells.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4507807

retrieved

27 July 2018

Serpins promote cancer cell survival and vascular co-option in brain metastasis

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4507807

retrieved

27 July 2018

Acquired resistance and clonal evolution in melanoma during BRAF inhibitor therapy

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4507807

retrieved

27 July 2018

A novel AKT1 mutant amplifies an adaptive melanoma response to BRAF inhibition

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4507807

retrieved

27 July 2018

Tumor adaptation and resistance to RAF inhibitors

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4507807

retrieved

27 July 2018

A melanocyte lineage program confers resistance to MAP kinase pathway inhibition

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4507807

retrieved

27 July 2018

Cancer drug resistance: an evolving paradigm

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4507807

retrieved

27 July 2018

Selection of bone metastasis seeds by mesenchymal signals in the primary tumor stroma.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4507807

retrieved

27 July 2018

ALK in lung cancer: past, present, and future

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4507807

retrieved

27 July 2018

Relief of profound feedback inhibition of mitogenic signaling by RAF inhibitors attenuates their activity in BRAFV600E melanomas

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4507807

retrieved

27 July 2018

STAR: ultrafast universal RNA-seq aligner

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4507807

retrieved

27 July 2018

A CXCL1 paracrine network links cancer chemoresistance and metastasis

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4507807

retrieved

27 July 2018

Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4507807

retrieved

27 July 2018

The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4507807

retrieved

27 July 2018

Melanoma whole-exome sequencing identifies (V600E)B-RAF amplification-mediated acquired B-RAF inhibitor resistance

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4507807

retrieved

27 July 2018

Survival in BRAF V600-mutant advanced melanoma treated with vemurafenib

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4507807

retrieved

27 July 2018

Programmed cell death in animal development and disease

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4507807

retrieved

27 July 2018

REVIGO summarizes and visualizes long lists of gene ontology terms

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4507807

retrieved

27 July 2018

Dissecting therapeutic resistance to RAF inhibition in melanoma by tumor genomic profiling

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4507807

retrieved

27 July 2018

Acquired resistance to BRAF inhibitors mediated by a RAF kinase switch in melanoma can be overcome by cotargeting MEK and IGF-1R/PI3K

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4507807

retrieved

27 July 2018

Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4507807

retrieved

27 July 2018

Differential expression analysis for sequence count data

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4507807

retrieved

27 July 2018

The RAF inhibitor PLX4032 inhibits ERK signaling and tumor cell proliferation in a V600E BRAF-selective manner

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4507807

retrieved

27 July 2018

Tumor self-seeding by circulating cancer cells

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4507807

retrieved

27 July 2018

Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4507807

retrieved

27 July 2018

Application of a translational profiling approach for the comparative analysis of CNS cell types

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4507807

retrieved

27 July 2018

A translational profiling approach for the molecular characterization of CNS cell types

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4507807

retrieved

27 July 2018

Melanoma and the tumor microenvironment

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4507807

retrieved

27 July 2018

Acquired resistance to tyrosine kinase inhibitors during cancer therapy

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4507807

retrieved

27 July 2018

Endogenous human microRNAs that suppress breast cancer metastasis

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4507807

retrieved

27 July 2018

Reversible and adaptive resistance to BRAF(V600E) inhibition in melanoma

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4507807

retrieved

24 September 2018

Treatment-induced damage to the tumor microenvironment promotes prostate cancer therapy resistance through WNT16B.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4507807

retrieved

24 September 2018

Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4507807

retrieved

24 September 2018

RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E)

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4507807

retrieved

24 September 2018

Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4507807

retrieved

24 September 2018

Improved survival with vemurafenib in melanoma with BRAF V600E mutation

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4507807

retrieved

24 September 2018

A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4507807

retrieved

24 September 2018

Identifiers

DOI

10.1038/NATURE14336

1 reference

stated in

Europe PubMed Central

PMC publication ID

4507807

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25807485%20AND%20SRC:MED&resulttype=core&format=json

retrieved

7 June 2020

Dimensions Publication ID

1044677141

0 references

PMC publication ID

4507807

1 reference

stated in

Europe PubMed Central

PMC publication ID

4507807

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25807485%20AND%20SRC:MED&resulttype=core&format=json

retrieved

7 June 2020

PubMed publication ID

25807485

1 reference

stated in

Europe PubMed Central

PMC publication ID

4507807

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25807485%20AND%20SRC:MED&resulttype=core&format=json

retrieved

7 June 2020

ResearchGate publication ID

274090804

0 references

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35867131&oldid=2197885887"